Home/Filings/4/0001179110-10-009389
4//SEC Filing

Brugger Stephen B 4

Accession 0001179110-10-009389

CIK 0001235010other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 2:35 PM ET

Size

5.5 KB

Accession

0001179110-10-009389

Insider Transaction Report

Form 4
Period: 2010-05-25
Brugger Stephen B
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2010-05-25$11.56/sh136$1,572255,532 total
Footnotes (2)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2006.
  • [F2]This transaction was executed in multiple trades at prices ranging from $11.56 to $11.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeother

Related Parties

1
  • filerCIK 0001294347

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 2:35 PM ET
Size
5.5 KB